Medicare Drug Price Negotiation Could Permanently Change What Americans Pay for Prescriptions

Why Codifying Most Favored Nation Drug Pricing Would Be A Mistake

America’s drug pricing crisis is real. Patients skip doses, seniors split pills, and employers shoulder rising health costs year after year. That frustration has made the idea of Most Favored Nation drug pricing politically attractive: if other wealthy countries pay less, why shouldn’t the United States? The problem is that codifying MFN into law would [] Why Codifying Most Favored Nation Drug Pricing Would Be A Mistake

MassHealth will stop covering weight-loss drugs next week

The change will leave an estimated 22,000 MassHealth members on the hook to pay out of pocket for the pricy GLP-1s and other anti-obesity drugs. The post MassHealth will stop covering weight-loss drugs next week appeared first on Boston.com.

Feds Aim to Tighten Drug Payment Loophole, Save Taxpayers Billions

A new proposed rule would cut Medicare reimbursement by 40 percent on prescription drugs for providers who already get large discounts.

Big Medicare change slashes weight-loss drug costs for eligible seniors

A new Medicare GLP-1 Bridge program offers Wegovy and Zepbound to eligible seniors for 50 a month starting July 1, slashing obesity drug costs.

Why Clinicians Worry Medicare’s New $50 Weight-Loss Program Could Backfire

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline has some experts expressing concern.

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

15 of Americans have ever taken the drugs, up from 6 in 2024.

Our Health Care System Is Broken Beyond Repair. We Need Medicare for All.

Repealing Medicare cuts and restoring ACA subsidies are the first step. But ultimately, we need universal health care.

Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees

Some Senate Democrats want to cap the amount beneficiaries in traditional Medicare have to pay toward care, but the move is expected to draw GOP opposition for potentially adding billions to Medicare costs.

Broker’s Call: Mankind Pharma (Add)

InCred Equities

MAHA: Big Change by CMS Over GLP-1 Drugs Could Affect Almost 4 Million Americans on Medicare

MAHA: Big Change by CMS Over GLP-1 Drugs Could Affect Almost 4 Million Americans on Medicare

I've been on GLP-1s for 16 months – here's why I won't be swapping to the new weight loss pill

Weight loss drug Wegovy is finally available in pill form, making it more accessible to people who want the benefits of GLP-1s – but is it worth making the swap?

Medicare will soon cover costs of weight-loss drugs. Here’s what you need to know

Popular Novo Nordisk and Eli Lilly drugs are included

New daily Wegovy pill goes on sale today: Full list of UK prices as pharmacies launch weight-loss tablet

New daily Wegovy pill goes on sale today: Full list of UK prices as pharmacies launch weight-loss tablet

Six Charged in $20 Million Medicare, Medicare Fraud Scheme Involving NJ Pharmacy

Six Charged in $20 Million Medicare, Medicare Fraud Scheme Involving NJ Pharmacy

Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know

NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans.

Thousands of Medicare Seniors Lost Prescription Drug Coverage Over Small Unpaid Premiums

Medicare Part D seniors are losing drug coverage over unpaid premiums as small as 8 after mid-year increases. Here's how to get reinstated and what rights you have now.

'Patients miss out': calls for reform to pharmacies

Australian pharmacies should be subjected to a host of reforms, a report suggests, including removing restrictions on where they can be built to improve access.

Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs

Medicare is launching a temporary bridge program that will cover select GLP-1 weight-loss medications from two of the pharmaceutical industry’s largest players. The program will extend coverage to Novo Nordisk’s (CPH: NOVO-B) Wegovy, both in injection and tablet form, marking a significant shift in how the federal health program approaches obesity treatment. Eli Lilly’s (NYSE: [] The post Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs appeared first on Foreign Policy Journal.

Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs

The Trump administration is proposing a new rule to keep hospitals from marking up discounted drugs for Medicare patients

CBI Home Health workers ask for 24% raise

They have also asked for market adjustments, long service adjustments, increases to shift premiums, and a reduction in health benefit premiums.

Weightloss injectable to become more accessible for Australians

Doctors say a pill version of the weightloss injectable Wegovy will make treatment more accessible for Australians.

What's the deal with ... microdosing Ozempic?

Can a smaller dose of GLP-1s cut side effects and costs? Experts weigh in on the rising trend of microdosing Ozempic and Wegovy.

Supreme Court loosens campaign finance laws, opening up flood of midterm cash

The change is likely to benefit Republicans, who brought the case and rely more on large donors.

Indiana U. fills 7 of 8 internal medicine slots with foreigners

Republican rep questions why American medical school slots are going to foreigners.

Prices Of Diabetes, Heart Disease, Hypertention And 36 Other Medicines Capped - Check Full

This move is expected to reduce out-of-pocket healthcare expenses, particularly for people requiring long-term treatment for chronic illnesses such as diabetes, hypertension and cardiovascular...

Washington’s $200 billion healthcare blind spot

As Congress debates Medicaid spending, Medicare solvency, and healthcare affordability, it continues to overlook a proven operational reform that could reduce U.S. hospital costs by more than 200 billion annually while improving patient safety, expanding access to care, and reducing workforce strain — without cutting benefits or increasing taxpayer spending. Healthcare affordability consistently ranks as []

Wegovy pills go on sale at Superdrug for £79 - as high street pharmacy becomes the first to launch weight-loss tablets

Wegovy pills go on sale at Superdrug for £79 - as high street pharmacy becomes the first to launch weight-loss tablets

The most quietly significant day of the decade is about to arrive

Stefano Hatfield: Weight-loss drugs in pill form will change Britain more than any of us can anticipate

Medicare patients could save $1.1B on drugs under proposed rule

The Trump administration proposed a new rule on Thursday that it says could save Medicare patients 1.1 billion next year. The rule would prevent hospitals from charging markups on discounted drugs, according to the Associated Press, and it would apply to hospitals that serve low-income patients under Medicare’s 340B program. The program allows hospitals to []...Click to read more

Americans Are Rethinking Supplements — This 25-Year Study Explains Why

Enter: The rise of personalized supplementation

Medicare Begins Covering Weight-Loss Drugs for Seniors, Ending a $50-a-Month Barrier

Medicare launched its GLP-1 Bridge program Tuesday, covering Wegovy and Zepbound for 10 million eligible seniors at 50 a month. It is the first time Medicare has covered a weight-loss drug specifically for obesity, not just diabetes: here is who qualifies and what doctors are warning.

Republicans can improve healthcare and lower costs

The Medicaid system incentivizes states and health insurance companies to enroll more patients, resulting in worse care and increased taxpayer costs, but market-based incentives could improve care and reduce costs.

Resident doctors vote to accept 6.6% pay uplift to end year of strike action

The new package includes standard 2016 resident doctor contract terms for all locally employed medics and an average 6.6 pay uplift by April 2027.

What Christians Need to Know about Senate's Proposed Insulin Price Cap, How Churches Can Support Diabetics

Staggering healthcare costs are crippling millions of Americans managing diabetes, forcing many to make impossible choices between vital medication and basic necessities. Explore how groundbreaking legislation and innovative community support, including a unique role for churches, are emerging to combat this crisis and offer crucial relief.

This New Medicare Option Could Be a Game Changer for Seniors

This long-awaited rule change is finally here.

Ferraris and Shell Companies: Five Charged in Medicare Fraud Schemes

Medicare paid over 10 billion in 2024 for expensive wound coverings called skin substitutes, a sudden spending spike that analysts have called one of the largest examples of waste in the federal health program’s history. The spending was fueled by multiple kickback schemes that enriched both the companies that manufactured skin substitutes and the doctors []

Medicaid funding restored for Planned Parenthood healthcare services

Republicans stripped Planned Parenthood and several other healthcare providers of Medicaid funding for one year, but now clinics can resume billing Medicaid for non-abortion services.

Health funding overhaul shows quiet shift in primary care reform - Cecilia Robinson

Health funding overhaul shows quiet shift in primary care reform - Cecilia Robinson

Sudan: Sudan's Aid Crisis Is Also a Crisis of Accountability

[The New Humanitarian] New York, United States -- What is needed is structural change: defining red lines... and being willing to escalate when those lines are crossed, publicly and collectively.